Los Angeles County Overdose Statistics 2024
Los Angeles County recorded 2,438 accidental drug overdose deaths in 2024 — the lowest number since 2019 and a 22% decline from 3,137 in 2023. It was the largest single-year drop in county history (LA County Department of Public Health, June 25, 2025).
The headline numbers
Total accidental drug overdose and poisoning deaths fell from 3,137 in 2023 to 2,438 in 2024 — a 22% decline and the lowest total since 2019. The age-adjusted rate was 23.1 deaths per 100,000 residents. Fentanyl-related deaths declined 37% (from 2,001 to 1,267). Methamphetamine-related deaths declined 20%. For the first time in several years, methamphetamine-involved deaths exceeded fentanyl-involved deaths.
Fentanyl's changing role
Fentanyl's share of accidental overdose deaths dropped from 64% in 2023 to 52% in 2024. This reflects both the sheer progress of the public health response (naloxone saturation, fentanyl test strips, Fentanyl Frontline campaign) and the persistent methamphetamine crisis. In 2024, methamphetamine overtook fentanyl as the drug most often listed in accidental overdose deaths, and by 2025 fentanyl's share had fallen to 49%, below methamphetamine's 61% (LA County SAPC).
Who fentanyl is killing in LA County
Adults aged 26–39 had the highest fentanyl death rate at 22.9 per 100,000 in 2024. Adults 40–64 were second at 18.8 per 100,000. By race and ethnicity, Hispanic/Latinx Angelenos accounted for 40% of fentanyl deaths (n=510), White Angelenos 36% (n=458), and Black Angelenos 18% (n=233). In the county's 2026 report, Black residents made up about 7% of the population but accounted for 20% of fentanyl overdose deaths in 2025 — a gap the county ties to economic, structural, and social factors that limit access to prevention and treatment.
The income gradient is stark
In 2025, the fentanyl overdose death rate in the least affluent LA County areas (more than 30% of families below the federal poverty level) was 5.4 times that of the most affluent areas (less than 10% below FPL) — 44.1 per 100,000 versus 8.1 per 100,000. That gradient shapes both overdose risk and treatment access. For immediate support any time, call or text 988 or call SAMHSA's National Helpline at 1-800-662-4357.
What public health did that worked
LA County scaled investments in substance use prevention by more than 260%, treatment by 275%, and harm reduction by 500% in 2024. The ByLAforLA.org platform connects residents with naloxone and peer support. Nationally, the FDA approved Narcan nasal spray for over-the-counter sale in March 2023, so it can be bought without a prescription. These efforts, combined with drug-supply shifts, drove the decline.
What the data does not mean
A 22% decline in one year is historic. It is not victory. 2,438 Angelenos died from overdose last year — roughly 47 per week, nearly seven per day. Fentanyl is still in more than half of overdose deaths. Methamphetamine is now the larger driver. Black Angelenos still account for a far larger share of fentanyl deaths than of the county population. The decline means the public health approach works. It does not mean the crisis is over.
FAQ
Common questions
Where does LA County publish this data?
The LA County Department of Public Health, through its Substance Abuse Prevention and Control (SAPC) bureau, releases periodic data reports. The 2024 summary was published June 25, 2025. The detailed fentanyl data report, updated in June 2026 with 2025 data, is published by the SAPC bureau at publichealth.lacounty.gov/sapc.
Is the decline likely to continue?
So far it has continued, more slowly. The county's June 2026 report shows fentanyl overdose deaths fell another 10% in 2025, after the 37% drop in 2024. Officials credit large investments in prevention, treatment, and harm reduction, and sustaining progress depends on keeping them in place.
Sources
- LA County Department of Public Health, news release on 2024 overdose deaths (June 25, 2025)
- LA County DPH, Substance Abuse Prevention and Control: Fentanyl Overdoses in Los Angeles County data report (June 2026)
- U.S. Food and Drug Administration, approval of the first over-the-counter naloxone nasal spray (March 29, 2023)
Last reviewed: